1. Home
  2. MAC vs BIO Comparison

MAC vs BIO Comparison

Compare MAC & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Macerich Company (The)

MAC

Macerich Company (The)

HOLD

Current Price

$22.61

Market Cap

7.2B

Sector

Real Estate

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$376.87

Market Cap

8.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAC
BIO
Founded
1964
1952
Country
United States
United States
Employees
2845
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Laboratory Analytical Instruments
Sector
Real Estate
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
8.0B
IPO Year
1994
1994

Fundamental Metrics

Financial Performance
Metric
MAC
BIO
Price
$22.61
$376.87
Analyst Decision
Buy
Buy
Analyst Count
12
4
Target Price
$20.50
$339.75
AVG Volume (30 Days)
2.5M
250.5K
Earning Date
05-06-2026
04-30-2026
Dividend Yield
3.12%
N/A
EPS Growth
11.36
142.61
EPS
N/A
N/A
Revenue
$1,013,983,000.00
$2,583,200,000.00
Revenue This Year
N/A
$2.74
Revenue Next Year
$4.80
$3.20
P/E Ratio
N/A
N/A
Revenue Growth
10.43
0.65
52 Week Low
$16.03
$236.73
52 Week High
$26.68
$396.23

Technical Indicators

Market Signals
Indicator
MAC
BIO
Relative Strength Index (RSI) 31.84 55.18
Support Level $22.13 $284.88
Resistance Level $25.97 $396.23
Average True Range (ATR) 0.54 9.71
MACD -0.04 -2.69
Stochastic Oscillator 19.16 38.92

Price Performance

Historical Comparison
MAC
BIO

About MAC Macerich Company (The)

Macerich invests in premium mall assets. The company owns 27 regional malls in its consolidated portfolio and 10 regional malls in its unconsolidated portfolio along with a power center and six other real estate assets. The company's total portfolio has 39.2 million square feet of gross leasable area and averaged $899 sales per square foot over the 12 months ended in March 2026.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: